NCT04692675View on ClinicalTrials.gov

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2031

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

mpMRI

3T endorectal coil MR imaging of the prostate gland

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH